Atea Pharmaceuticals, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Atea Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2019 to Q4 2023.
  • Atea Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $74.2M, a 80.2% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $74.2M +$33M +80.2% Dec 31, 2023 10-K 2024-02-28
Q4 2022 $41.2M +$30.3M +277% Dec 31, 2022 10-K 2024-02-28
Q4 2021 $10.9M -$6.08M -35.8% Dec 31, 2021 10-K 2023-02-28
Q4 2020 $17M +$1.89M +12.5% Dec 31, 2020 10-K 2022-02-28
Q4 2019 $15.1M Dec 31, 2019 10-K 2021-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.